Reading Time: 7 minutesResearchers from the University of Aberdeen and the University of Edinburgh have developed a new tool that could help to detect signs of MND in
Tag: TDP-43
Causes and disease mechanisms Genetic Research Markers of Disease Progression MND Research Models of MND Research we fund Treatments
Celebrating the contribution of Women to MND research
Reading Time: 7 minutesEach year the 11th of February sees the world recognise and celebrate the contributions of women in science. The International day of Women and Girls
Reading Time: 5 minutesLast month we held the 34th International Symposium on ALS/MND in Basel Switzerland. This huge event allows people from across the world to come and
34th Symposium: Basel Causes and disease mechanisms Clinical Trials Genetic Research Healthcare Markers of Disease Progression MND Research Models of MND Research we fund Symposium Treatments
Symposium Preview: Meet the Symposium Communications Ambassadors
Reading Time: 7 minutesEach year at the Symposium, there is a huge amount of research presented on a range of topics from across the globe. With the Symposium returning to an in-person event this year, we are keen to increase the number of updates we share for those not able to attend, including people living with and affected by MND.
To help us do this, we have launched a new Symposium Communications Ambassador Programme so we can bring more of the research from the Symposium to non-scientific audiences. This programme was open for applications from early career researchers working in MND, who were interested in helping us shine a light on MND research happening across the world. This year we have 5 early career researchers taking part in the Programme, who will gain experience and new skills in communicating research to different audiences. Before, during and after the Symposium our Ambassador’s will be helping us to share the latest research with the MND community.
34th Symposium: Basel Causes and disease mechanisms Clinical Trials Events Genetic Research Markers of Disease Progression MND Research Symposium
Symposium Preview: Meet the ALS/MND Plenary Speakers…Part 2
Reading Time: 7 minutesEach year we invite plenary speakers who are experts in their fields to provide an overview on topics across MND research and clinical practice. This year we have 14 plenary speakers talking about ALS/MND who will discuss a wide range of topics from genetics to tissue biomarkers to improving clinical practice. In this second blog we will be taking a closer look at some of our plenary speakers this year and sharing more about the topics they will be discussing.
Reading Time: 4 minutesMy name is Dr Hannah Smith, and I’m a post-doctoral researcher at the University of Edinburgh. My project is supervised by Professor Tom Gillingwater, and my work is funded by MND Scotland. My current research focuses on comparing healthy motor neurons and those with MND/ALS, specifically focusing on early changes to the cellular machinery and how the motor neurons produce the proteins they need to function. I’ll discuss the specifics of that, and why we are interested in finding out this information, in the next section.
Reading Time: 5 minutesHi there! I’m Dezerae, and I am currently a Lady Edith Wolfson Junior Non-Clinical Research Fellow at the University of Cambridge. My work, supported by
Reading Time: 6 minutesQurAlis, a biotechnology company focused on developing precision medicines for MND and other neurodegenerative diseases, has announced the opening of a clinical trial in the
